• Denmark

Danish Pharma Stocks Analysis

CPSE:ALK B
CPSE:ALK B
CPSE:ALK BPharmaceuticals

Private equity firms among ALK-Abelló A/S' (CPH:ALK B) largest shareholders, saw gain in holdings value after stock jumped 5.4% last week

June 24, 2022
Every investor in ALK-Abelló A/S ( CPH:ALK B ) should be aware of the most powerful shareholder groups. With 41% stake...
CPSE:NOVO B
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

How Much Of Novo Nordisk A/S (CPH:NOVO B) Do Institutions Own?

June 21, 2022
Every investor in Novo Nordisk A/S ( CPH:NOVO B ) should be aware of the most powerful shareholder groups. Institutions...
CPSE:NOVO B
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

Has Novo Nordisk A/S' (CPH:NOVO B) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

June 05, 2022
Novo Nordisk's (CPH:NOVO B) stock is up by a considerable 11% over the past three months. We wonder if and what role...
CPSE:ALK B
CPSE:ALK B
CPSE:ALK BPharmaceuticals

Should Weakness in ALK-Abelló A/S' (CPH:ALK B) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

June 03, 2022
With its stock down 9.0% over the past month, it is easy to disregard ALK-Abelló (CPH:ALK B). But if you pay close...
CPSE:LUN
CPSE:LUN
CPSE:LUNPharmaceuticals

H. Lundbeck A/S' (CPH:LUN) last week's 3.2% decline must have disappointed private equity firms who have a significant stake

May 25, 2022
If you want to know who really controls H. Lundbeck A/S ( CPH:LUN ), then you'll have to look at the makeup of its...
CPSE:NOVO B
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

If You Like EPS Growth Then Check Out Novo Nordisk (CPH:NOVO B) Before It's Too Late

May 21, 2022
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
CPSE:ALK B
CPSE:ALK B
CPSE:ALK BPharmaceuticals

We Think ALK-Abelló (CPH:ALK B) Can Manage Its Debt With Ease

May 12, 2022
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
CPSE:NOVO B
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

Investing in Novo Nordisk (CPH:NOVO B) five years ago would have delivered you a 219% gain

May 05, 2022
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
CPSE:LUN
CPSE:LUN
CPSE:LUNPharmaceuticals

The past five years for H. Lundbeck (CPH:LUN) investors has not been profitable

May 04, 2022
For many, the main point of investing is to generate higher returns than the overall market. But every investor is...
  • 1
  • 2
  • 3
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.